MAIAClinical•businesswire•
MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies
Sentiment:Positive (80)
Summary
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 18, 2025 by businesswire